Sort
15,842 grants matching “pancreatic cancer”
Pancreatic Ductal Adenocarcinoma Translational Resource Center (PATReC)
$559,976Anirban Maitra · University Of Tx Md Anderson Can Ctr · U24 · FY2020 · CA
Novel Determinants and Measures of Smokeless Tobacco Use
$559,824Dorothy K Hatsukami · University Of Minnesota · R01 · FY2010 · CA
ROLE OF IL-23 IN EPITHELIAL-TO-MESENCHYMAL CONVERSION IN PANCREATIC CANCER
$559,799University Of North Carolina At Chapel Hill · · FY2019 · Department of the Army
PET Imaging-guided Personalized Therapy in Pancreatic Cancer
$559,454Caius Gabriel Radu · University Of California Los Angeles · R01 · FY2015 · CA
T Cell Alternative p38 Activation Pathway
$559,431Jonathan Ashwell · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Multiplexed Serum Biomarkers for Pancreatic Cancer
$559,273Anna E Lokshin · University Of Pittsburgh At Pittsburgh · U01 · FY2008 · CA
Oncogenic Met Signaling in Urologic Malignancies
$558,896Donald Bottaro · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Genome topology in the filamentous fungus Neurospora crassa: organizing factors and impact on genome function
$558,750Andrew David Klocko · University Of Colorado · R15 · FY2025 · GM
Pharmacogenomic and circulating tumor cell approach to individualized treatment of pancreatic cancer
$558,719Kenneth H. Yu · Sloan-Kettering Inst Can Research · R01 · FY2019 · CA
MR-HIFU induced drug delivery for pancreatic cancer treatment
$558,396Donghoon Lee · University Of Washington · R01 · FY2015 · CA
Genomic and genetic studies of endocrine cancers
$558,362Electron Kebebew · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
New Tools for Prostate Cancer Detection and Prognostication
$558,198Sanjiv S Gambhir · Stanford University · U01 · FY2011 · CA
Pharmacogenomic and circulating tumor cell approach to individualized treatment of pancreatic cancer
$558,143Kenneth H. Yu · Sloan-Kettering Inst Can Research · R01 · FY2018 · CA
Pharmacogenomic and circulating tumor cell approach to individualized treatment of pancreatic cancer
$558,143Kenneth H. Yu · Sloan-Kettering Inst Can Research · R01 · FY2017 · CA
Label free microfluidic isolation, characterization and ex vivo expansion of CTCs
$557,904Sunitha Nagrath · University Of Michigan At Ann Arbor · R01 · FY2021 · CA
Label free microfluidic isolation, characterization and ex vivo expansion of CTCs
$557,904Sunitha Nagrath · University Of Michigan At Ann Arbor · R01 · FY2020 · CA
Little Cigar and Cigarillo Warnings to Reduce Tobacco-Related Cancers and Disease
$557,901Adam O Goldstein · Univ Of North Carolina Chapel Hill · R01 · FY2022 · CA
Developing translationally-relevant genetically engineered mouse models of lung adenocarcinoma for investigations in cancer immunology
$557,766Nikhil Joshi · Yale University · R01 · FY2022 · CA
Developing translationally-relevant genetically engineered mouse models of lung adenocarcinoma for investigations in cancer immunology
$557,766Nikhil Joshi · Yale University · R01 · FY2020 · CA
Developing translationally-relevant genetically engineered mouse models of lung adenocarcinoma for investigations in cancer immunology
$557,766Nikhil Joshi · Yale University · R01 · FY2021 · CA
Multiplexed Serum Biomarkers for Pancreatic Cancer
$557,662Anna E Lokshin · University Of Pittsburgh At Pittsburgh · U01 · FY2007 · CA
University of Texas PDX Development and Trial Center
$557,633Jack Roth · University Of Tx Md Anderson Can Ctr · U54 · FY2022 · CA
Synthetic circuits that drive infiltration of therapeutic T cells into immunologically cold tumors
$557,412Wendell A Lim · University Of California, San Francisco · U01 · FY2024 · CA
Defining metabolic adaptations within the PDAC "arid" tumor microenvironment
$557,401Chi V. Dang · Johns Hopkins University · R01 · FY2025 · CA
Targeting Focal Adhesion Kinase to Improve RT-inducted Tumor Immunity
$557,274David G Denardo · Washington University · R01 · FY2022 · CA